These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 3323750)
1. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev; 1987 Dec; 58(4):325-37. PubMed ID: 3323750 [No Abstract] [Full Text] [Related]
2. Characteristics of patients in the THELEP trials of chemotherapy of leprosy at Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev; 1987 Mar; 58(1):7-16. PubMed ID: 3298905 [No Abstract] [Full Text] [Related]
3. Primary dapsone resistance in Bamako and Chingleput: final report; THELEP. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev; 1987 Sep; 58(3):209-18. PubMed ID: 3312895 [No Abstract] [Full Text] [Related]
4. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197 [TBL] [Abstract][Full Text] [Related]
5. The THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):864-71. PubMed ID: 3325580 [No Abstract] [Full Text] [Related]
6. Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev; 1988 Mar; 59(1):5-10. PubMed ID: 3294541 [No Abstract] [Full Text] [Related]
7. Third annual report of the UNDP/World Bank/who special programme for research and training in tropical diseases. Dharmendra Lepr India; 1980 Oct; 52(4):595-602. PubMed ID: 7007726 [No Abstract] [Full Text] [Related]
8. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients. Grange JM; Beck JS; Abbot NC Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236 [No Abstract] [Full Text] [Related]
9. Fourth annual report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Dharmendra Lepr India; 1981 Jul; 53(3):487-93. PubMed ID: 7024635 [No Abstract] [Full Text] [Related]
10. Prospects for chemotherapy of leprosy. Ji B Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659 [No Abstract] [Full Text] [Related]
11. National Leprosy Eradication Programme, India. National Action Plan for 2006-07. Central Leprosy Division of the Directorate General of Health Services Indian J Lepr; 2006; 78(1):48-50. PubMed ID: 16646283 [No Abstract] [Full Text] [Related]
12. Supervised administration of multidrug therapy in leprosy colonies through volunteers--a bacteriological assessment. Ganapati R; Naik SS; Revankar CR; Vartak RB; Desai AP; Panvalkar NA; Deshpande SS Indian J Lepr; 1986; 58(1):86-90. PubMed ID: 3528338 [No Abstract] [Full Text] [Related]
13. [Summary of the experimental protocols for polychemotherapy of leprosy undertaken since 1977 at the Institut Marchoux, Bamako. Results as of 31 December, 1985]. Nebout M; Husser JA; GrossetĂȘte G; Fofana Y; Daumerie D; Traore I Acta Leprol; 1987; 5(3):219-29. PubMed ID: 3321856 [No Abstract] [Full Text] [Related]
14. [New WHO recommendations for the treatment of leprosy]. Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754 [No Abstract] [Full Text] [Related]
15. Solid, fragmented and granular index as one of the parameters in drug trials. Sharma VD; Ramu G; Dutta AK; Katoch K; Ramanathan U Lepr India; 1982 Jul; 54(3):448-53. PubMed ID: 6757578 [TBL] [Abstract][Full Text] [Related]
16. A plea to revive skin smear examination. Porichha D Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):116-9. PubMed ID: 11757169 [No Abstract] [Full Text] [Related]
17. Multidrug therapy--the pathway for global leprosy elimination. al-Qubati Y; al-Kubati AS Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482 [TBL] [Abstract][Full Text] [Related]
18. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Jamet P; Ji B Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967 [No Abstract] [Full Text] [Related]
19. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India. Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718 [TBL] [Abstract][Full Text] [Related]
20. Report of the Third Meeting of the Scientific Working Group on Chemotherapy of Leprosy (THELEP) of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, 20-22 October 1980. Lepr Rev; 1981 Dec; 52(4):349-54. PubMed ID: 7031391 [No Abstract] [Full Text] [Related] [Next] [New Search]